Medindia

X

A New Addition Could Help Patients With Parkinsonís Disease

by Medindia Content Team on  March 21, 2005 at 5:22 PM General Health News   - G J E 4
A New Addition Could Help Patients With  Parkinsonís Disease
Researchers say by adding the drug rasagiline to standard treatment with levodopa can reduce the amount of time Parkinson's disease patients spend suffering from motor fluctuations they experience during the day .
Advertisement

For the study researchers compared once-daily oral rasagiline to the drug entacapone, which must be taken with every levodopa dose, and a placebo in around 690 patients. Both of the additional drugs were effective in reducing the amount of "off time" defined as periods during the day when patients have symptoms. Rasagiline reduced "off time" on average by 1.18 hours, compared to 1.2 hours for entacapone. The drug was also found to be well-tolerated in the older age groups, with no evidence of an increase in hallucinations or occurrence of other common side effects of Parkinson's drugs, such as daytime sleepiness, nausea, and leg swelling.

Advertisement
In conclusion researchers say they feel that the drug is likely to find favor with both neurologists and geriatricians as a useful addition to Parkinson's disease therapeutics.
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All